Bpi Labs patents expiration
1. Epinephrine patents expiration
EPINEPHRINE Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10039728 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
| US10004700 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
| US9283197 | BPI LABS | More potent and less toxic formulations of epinephrine and methods of medical use |
Aug, 2034
(10 years from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 04 February, 2022
Treatment: Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating...
Dosage: SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
How can I launch a generic of EPINEPHRINE before it's drug patent expiration?
More Information on Dosage
EPINEPHRINE family patents
